𝛼SK or Search

ENTITY

Medtide (3880 HK)

6

Analysis

Health Care • China

Medtide is a China-based, peptide-focused contract research, development, and manufacturing organization (CRDMO). It offers full-cycle services from early-stage discovery, preclinical research, and clinical development to commercial-stage production of peptide new chemical entities (NCEs) and active pharmaceutical ingredients (APIs). The company was founded in 2020 and is headquartered in Hangzhou, China.

more

Refresh

Exchange Announcement • 24 Sep 2026 16:47

Voluntary Announcement Update On The Strategic Expansion Of Large-Scale Peptide Cdmo Production Capacity

Exchange Announcement • 24 Sep 2026 16:45

List Of Directors And Their Roles And Functions

Exchange Announcement • 24 Sep 2026 16:43

Resignation Of Executive Director

Exchange Announcement • 24 Sep 2026 16:37

Notification Letter And Reply Form To Non-Registered Shareholders - Reminder Letter Regarding The Arrangement Of Electronic Dissemination Of Corporate Communications

Exchange Announcement • 24 Sep 2026 16:35

Notification Letter And Reply Form To Registered Shareholders - Reminder Letter Regarding The Arrangement Of Electronic Dissemination Of Corporate Communications

Copyright © 2022 Smartkarma Innovations Pte Ltd. All Rights Reserved. v3.70.4

x